The Scientific Advisors and Researchers team at Coave Therapeutics plays a pivotal role in advancing the development of gene therapy products for rare ophthalmic diseases. Comprised of experts in various scientific disciplines, the team is responsible for guiding research strategies, conducting preclinical studies, and ensuring that innovative therapies effectively target and treat underlying conditions. Their collaborative efforts are crucial for translating scientific discoveries into viable clinical applications that preserve visual autonomy for patients.
Alain Wagner
Scientific Advisor
Andrea Ballabio
Scientific Advisor
Aravind Asokan
Scientific Advisor
Claudia Mitchell
Interim Chief Scientific Offic...
Erwan Bézard
Scientific Advisor
Gaelle Lefevre
Head, Discovery Sciences
Juliette Hordeaux
Scientific Advisor
Marie-Anne Burlot
Preclinical Manager
Mark Kay
Scientific Advisor
Robert Kotin
Scientific Advisor
View all